We have previously reported defects in the insulin signalling pathway in peripheral tissues of rodents that underwent IUGR followed by catch-up growth [16, 17] and similar differences in adipose and muscle biopsies from low-birthweight humans [14, 18]. The gene discussed is INS; the disease is fetal growth restriction.